Bellerophon Therapeutics, Inc.
BLPH
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.56% | -30.30% | 119.12% | -38.82% | -30.69% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.14% | 190.21% | -17.09% | -30.77% | 31.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.93% | -73.58% | 0.00% | 0.25% | 0.25% |
| Total Current Assets | -55.72% | -28.70% | 108.53% | -37.28% | -29.01% |
|
|
|||||
| Total Current Assets | -55.72% | -28.70% | 108.53% | -37.28% | -29.01% |
| Net Property, Plant & Equipment | -- | -- | -95.16% | -48.76% | -34.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Assets | -55.72% | -29.57% | 101.21% | -37.06% | -28.89% |
|
|
|||||
| Total Accounts Payable | -67.57% | 76.36% | -13.01% | -19.34% | -24.02% |
| Total Accrued Expenses | -82.76% | -12.86% | 8.01% | 21.79% | 14.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -96.06% | -48.74% | -32.42% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -77.66% | 4.81% | -0.69% | 4.29% | -4.96% |
|
|
|||||
| Total Current Liabilities | -77.66% | 4.81% | -0.69% | 4.29% | -4.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | -77.66% | 4.81% | -0.69% | 4.27% | -4.95% |
|
|
|||||
| Common Stock & APIC | 0.01% | 0.06% | 2.06% | 0.05% | 0.09% |
| Retained Earnings | -0.76% | -2.06% | 1.12% | -2.03% | -2.09% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -33.79% | -46.96% | 318.39% | -65.89% | -39.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.79% | -46.96% | 318.39% | -65.89% | -39.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.79% | -46.96% | 318.39% | -65.89% | -39.51% |
|
|
|||||
